But, for those who had gallbladder removal surgery, there are worries about its safety and how well it works
Braca is the lead author of a new study recently presented at the European Academy of Neurology (EAN) Congress 2025 that has found that glucagon-like peptide-1 (GLP-1) receptor agonist medications used to treat type 2 diabetes and obesity may help cut a persons monthly migraine days by about half
Confirm that weight-loss drugs are excluded under your plan's benefit design
Latest GLP-1 Study 2025: Key Findings Everyone Is Talking About The latest GLP-1 study 2025 (ATTAIN-1) shows that orforglipron led to meaningful weight loss, better metabolic control, and improvements in heart-related markers
Centralized Data for Clinicians Platforms like MeAgain centralize injection timing, side-effect logging, nutrition, and activity, so third-party data becomes a concise timeline that clinicians can act on without extensive reconstruction
& Ghoos, Y